Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) just unveiled an announcement.
Daito Pharmaceutical Co., Ltd. has announced the repurchase of its own shares, acquiring 124,100 shares at a total cost of 153,432,400 yen through market purchases on the Tokyo Stock Exchange. This move is part of a larger plan approved by the Board of Directors to repurchase up to 1,000,000 shares, equivalent to 3.3% of the total issued shares, with a budget of up to 1,500 million yen, aiming to enhance shareholder value.
The most recent analyst rating on (JP:4577) stock is a Hold with a Yen1261.00 price target. To see the full list of analyst forecasts on Daito Pharmaceutical Co., Ltd. stock, see the JP:4577 Stock Forecast page.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 65,906
Technical Sentiment Signal: Buy
Current Market Cap: Yen39.48B
See more insights into 4577 stock on TipRanks’ Stock Analysis page.